Efficacy and safety of low-dose everolimus in Chinese HR-positive, HER2-negative metastatic breast cancer patients.

被引：1
|
作者：
Shao, Xiying
Zheng, Yabing
Chen, Zhan-Hong
Li, Guangliang
Jia, Wang Xiao
机构：
[1] Zhejiang Canc Hosp, Hangzhou, Peoples R China
[2] Zhejiang Canc Hosp, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e13035
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13035
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of low-dose everolimus in Chinese HR-positive, HER2-negative metastatic breast cancer patients
    Shao, X.
    Wang, X.
    Chen, Z.
    Zheng, Y.
    CANCER RESEARCH, 2019, 79 (04)
  • [2] Role of everolimus in the treatment of metastatic HER2-negative/HR-positive breast cancer
    Pronzato, Paolo
    FUTURE ONCOLOGY, 2017, 13 (16) : 1371 - 1384
  • [3] Efficacy, safety, and predictive model of Palbociclib in the treatment of HR-positive and HER2-negative metastatic breast cancer
    Wang, Wei
    Lei, Wenqian
    Fang, Ziru
    Jiang, Ruiyuan
    Wang, Xiaojia
    BMC CANCER, 2024, 24 (01)
  • [4] Efficacy, safety, and predictive model of Palbociclib in the treatment of HR-positive and HER2-negative metastatic breast cancer
    Wei Wang
    Wenqian Lei
    Ziru Fang
    Ruiyuan Jiang
    Xiaojia Wang
    BMC Cancer, 24
  • [5] Systemic Therapy of HR-positive, HER2-negative metastatic Breast Cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (03) : 257 - 257
  • [6] Sacituzumab Govitecan in HR-positive HER2-negative metastatic breast cancer
    Nardin, Simone
    Del Mastro, Lucia
    ANNALS OF TRANSLATIONAL MEDICINE, 2023,
  • [7] Ribociclib in HR-positive, HER2-negative breast cancer
    Burki, Talha Khan
    LANCET ONCOLOGY, 2016, 17 (11): : E482 - E482
  • [8] Establishment of Prognostic Nomograms for Predicting the Survival of HR-Positive, HER2-Negative Metastatic Breast Cancer Patients Treated with Everolimus
    Duan, Fangfang
    Song, Chenge
    Ma, Yuyu
    Jiang, Kuikui
    Xu, Fei
    Bi, Xiwen
    Huang, Jiajia
    Hong, Ruoxi
    Huang, Zhangzan
    Lu, Qianyi
    Yuan, Zhongyu
    Wang, Shusen
    Xia, Wen
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 3463 - 3473
  • [9] Combined everolimus and endocrine therapy in advanced HR-positive, HER2-negative Chinese breast cancer patients: a retrospective study
    Shen, Xia-Bo
    Li, Guang-Liang
    Zheng, Ya-Bing
    Chen, Zhan-Hong
    Cao, Wen-Ming
    Wang, Xiao-Jia
    Shao, Xi-Ying
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (16)
  • [10] Palbociclib: A Review in HR-Positive, HER2-Negative, Advanced or Metastatic Breast Cancer
    Kim, Esther S.
    Scott, Lesley J.
    TARGETED ONCOLOGY, 2017, 12 (03) : 373 - 383
12345